🧴 Topical Retinoid Skin Cell Turnover Simulator
This simulation models the process of skin cell turnover using topical retinoids. It illustrates how these medications affect the epidermis and dermis, promoting healthier skin regeneration and addressing various skin conditions.
Abnormal Keratinization — How Comedones Form
Sticky corneocytes fail to shed, plugging the follicle.
- 28 days: Epidermal Turnover (Retained corneocytes shed slowly here.)
- High: Follicular Plug Density (Cells cohere, blocking the pore opening.)
- Micro → Macro: Comedone Type (Blackhead or whitehead forms over weeks.)
- Elevated: Sebum Trapped (Trapped oil feeds bacterial overgrowth.)
Hypercohesive corneocytes
Excess keratin and sticky cell junctions trap dead skin cells.
Follicle occlusion
Trapped debris and sebum form a visible or invisible plug.
Microcomedones can form weeks before any visible lesion appears.
Application & Penetration Into the Epidermis
A lipophilic retinoid crosses the stratum corneum barrier.
- Tretinoin / Adapalene: Molecule (Lipophilic compounds cross the skin barrier.)
- ~2-4 hrs: Penetration Time (Reaches the basal keratinocyte layer.)
- Cream / Gel: Vehicle (Formulation affects irritation and absorption.)
- ~2-5%: Systemic Bioavailability (Most retinoid stays within skin layers.)
Barrier crossing
Lipophilic structure lets the molecule diffuse through corneocytes.
Reaching target cells
Retinoid accumulates near basal and follicular keratinocytes.
Adapalene is more photostable and better tolerated than tretinoin.
Retinoic Acid Receptors Rewrite the Genetic Program
RAR/RXR heterodimers bind DNA and change gene transcription.
- RAR-α/β/γ: Receptor Type (Nuclear hormone receptor family members.)
- 100+: Genes Modulated (Differentiation and cohesion gene targets.)
- Hours-Days: Transcription Shift (mRNA changes precede visible skin effects.)
- Reduced: Cell Cohesion (Corneocytes stick together less strongly.)
RAR/RXR heterodimer
Retinoic acid binds the receptor, activating target gene sites.
Differentiation reprogrammed
Keratinocyte maturation and shedding genes get switched on.
This transcriptional shift is the core mechanism behind retinoids.
Turnover Normalizes, Follicle Openings Clear
Keratinocytes now shed individually instead of clumping.
- ~14 days: New Turnover Rate (Roughly twice the baseline shedding speed.)
- Restored: Follicle Patency (Openings stay clear of trapped debris.)
- ↓ 40-70%: Comedone Formation (Fewer new plugs form over time.)
- 8-12 weeks: Visible Onset (Full benefit takes patience to appear.)
Single-cell shedding
Cells detach one at a time rather than in clumps.
Pore clearing
Follicle openings stay unblocked, preventing new comedones.
Consistent daily use matters more than raw retinoid strength.
The Purge Window, Then Sustained Clearance
Existing microcomedones surface faster before overall improvement.
- Weeks 2-6: Purge Window (Existing microcomedones surface faster first.)
- ~12 weeks: Improvement Onset (Visible clearing follows once purge subsides.)
- ~50-70%: Lesion Reduction (Typical result seen with consistent use.)
- Ongoing: Maintenance (Stopping treatment reverses the benefit gained.)
Why purging happens
Retinoids accelerate microcomedones already forming beneath the surface.
Past the dip
New comedone formation slows, and skin texture improves.
Purging is temporary; discontinuing early forfeits the improvement.
This simulation models the process of skin cell turnover using topical retinoids. It illustrates how these medications affect the epidermis and dermis, promoting healthier skin regeneration and addressing various skin conditions.
2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install